Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 1/20 | 0.71 |
| ▸ | KCNH3 | Q9ULD8 | 5/20 | 0.65 |
| ▸ | IDH1 | O75874 | 11/20 | 0.54 |
| ▸ | IDH2 | P48735 | 9/20 | 0.54 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.52 |
| ▸ | TSHR | P16473 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15102366 | 0.88 | KCNH3 (0.66) | POLBKCNH3IDH1IDH2 | |
| SCHEMBL29560995 | 0.88 | KCNH3 (0.66) | POLBKCNH3IDH1IDH2 | |
| SCHEMBL15102422 | 0.85 | IDH1 (0.62) | POLBIDH1IDH2 | |
| SCHEMBL16393101 | 0.84 | IDH1 (0.71) | IDH1IDH2 | |
| SCHEMBL29763331 | 0.84 | RHOA (0.56) | POLBKCNH3IDH1IDH2 | |
| SCHEMBL15094676 | 0.84 | RHOA (0.56) | POLBKCNH3IDH1IDH2 | |
| SCHEMBL15102514 | 0.83 | IDH1 (0.57) | POLBKCNH3IDH1IDH2 | |
| SCHEMBL15102285 | 0.83 | IDH1 (0.53) | POLBKCNH3IDH1IDH2 | |
| SCHEMBL29561084 | 0.83 | IDH1 (0.53) | POLBKCNH3IDH1IDH2 | |
| SCHEMBL15094853 | 0.82 | KCNH3 (0.49) | POLBKCNH3IDH1IDH2TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3984997-A1 | THERAPEUTICALLY ACTIVE COMPOUNDS AND THEIR METHODS OF USE | Les Laboratoires Servier SAS (FR) | 2022-04-20 | — | — | EP | disclosed |
| EP-2800743-B1 | THERAPEUTICALLY ACTIVE COMPOUNDS AND THEIR METHODS OF USE | AGIOS PHARMACEUTICALS INC (US) | 2018-04-04 | — | — | EP | disclosed |